1. Home
  2. GRPN vs CGEM Comparison

GRPN vs CGEM Comparison

Compare GRPN & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Groupon Inc.

GRPN

Groupon Inc.

N/A

Current Price

$16.20

Market Cap

723.4M

ML Signal

N/A

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

N/A

Current Price

$9.58

Market Cap

671.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GRPN
CGEM
Founded
2008
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
723.4M
671.7M
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
GRPN
CGEM
Price
$16.20
$9.58
Analyst Decision
Buy
Strong Buy
Analyst Count
4
8
Target Price
$31.25
$28.00
AVG Volume (30 Days)
978.3K
1.5M
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$496,093,000.00
N/A
Revenue This Year
$4.17
N/A
Revenue Next Year
$10.63
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.21
$5.68
52 Week High
$43.08
$13.33

Technical Indicators

Market Signals
Indicator
GRPN
CGEM
Relative Strength Index (RSI) 42.09 44.82
Support Level $15.50 $10.01
Resistance Level $17.46 $13.10
Average True Range (ATR) 0.84 1.00
MACD 0.02 -0.27
Stochastic Oscillator 22.49 3.73

Price Performance

Historical Comparison
GRPN
CGEM

About GRPN Groupon Inc.

Groupon Inc acts as the middleman between consumers and merchants, offering products and services at discounts via its online store. It offers consumers daily deals from local merchants. The company's operations are organized into two segments: North America and International. The company generates the majority of its revenue from North America. The company generates revenue from transactions during which the company generates commissions by selling goods or services on behalf of third-party merchants. Revenue also includes commissions the company earn when customers make purchases with retailers using digital coupons accessed through its digital properties.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: